Chevy Chase Trust’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$151M Sell
1,253,128
-38,375
-3% -$4.43M 0.43% 45
2025
Q4
$136M Sell
1,291,503
-20,347
-2% -$1.91M 0.37% 49
2025
Q3
$110M Sell
1,311,850
-53,574
-4% -$4.41M 0.3% 64
2025
Q2
$108M Sell
1,365,424
-3,124
-0.2% -$248K 0.31% 61
2025
Q1
$123M Sell
1,368,548
-1,878
-0.1% -$175K 0.39% 48
2024
Q4
$136M Sell
1,370,426
-35,986
-3% -$3.71M 0.42% 40
2024
Q3
$160M Sell
1,406,412
-28,742
-2% -$3.41M 0.49% 35
2024
Q2
$178M Sell
1,435,154
-21,844
-1% -$2.81M 0.57% 29
2024
Q1
$192M Sell
1,456,998
-13,891
-0.9% -$1.71M 0.63% 27
2023
Q4
$160M Sell
1,470,889
-14,246
-1% -$1.48M 0.57% 27
2023
Q3
$153M Sell
1,485,135
-31,745
-2% -$3.42M 0.6% 29
2023
Q2
$175M Sell
1,516,880
-15,300
-1% -$1.74M 0.66% 26
2023
Q1
$163M Buy
1,532,180
+11,099
+0.7% +$1.2M 0.65% 29
2022
Q4
$169M Sell
1,521,081
-88,211
-5% -$9.02M 0.72% 28
2022
Q3
$139M Buy
1,609,292
+19,497
+1% +$1.74M 0.59% 33
2022
Q2
$145M Buy
1,589,795
+6,744
+0.4% +$598K 0.6% 33
2022
Q1
$130M Buy
1,583,051
+1,933
+0.1% +$152K 0.45% 46
2021
Q4
$121M Sell
1,581,118
-40,093
-2% -$3.19M 0.39% 58
2021
Q3
$122M Sell
1,621,211
-62,440
-4% -$4.75M 0.42% 51
2021
Q2
$131M Sell
1,683,651
-172,331
-9% -$12.8M 0.45% 47
2021
Q1
$137M Sell
1,855,982
-130,263
-7% -$9.61M 0.49% 40
2020
Q4
$155M Sell
1,986,245
-69,390
-3% -$5.31M 0.55% 34
2020
Q3
$163M Sell
2,055,635
-180,926
-8% -$14.2M 0.64% 27
2020
Q2
$165M Sell
2,236,561
-161,672
-7% -$12.2M 0.67% 26
2020
Q1
$176M Buy
2,398,233
+23,044
+1% +$1.81M 0.82% 22
2019
Q4
$206M Sell
2,375,189
-14,871
-0.6% -$1.22M 0.78% 24
2019
Q3
$192M Sell
2,390,060
-10,369
-0.4% -$831K 0.79% 25
2019
Q2
$192M Sell
2,400,429
-6,366
-0.3% -$487K 0.8% 26
2019
Q1
$181M Buy
2,406,795
+3,352
+0.1% +$251K 0.75% 26
2018
Q4
$175M Sell
2,403,443
-38,646
-2% -$2.73M 0.85% 19
2018
Q3
$165M Sell
2,442,089
-89,538
-4% -$5.7M 0.69% 29
2018
Q2
$147M Sell
2,531,627
-37,093
-1% -$2.09M 0.64% 31
2018
Q1
$134M Sell
2,568,720
-566,653
-18% -$30.6M 0.59% 36
2017
Q4
$168M Sell
3,135,373
-69,480
-2% -$3.85M 0.73% 27
2017
Q3
$196M Buy
3,204,853
+37,781
+1% +$2.29M 0.89% 22
2017
Q2
$194M Sell
3,167,072
-456
-0% -$27.8K 0.93% 19
2017
Q1
$192M Buy
3,167,528
+108,068
+4% +$6.56M 0.94% 19
2016
Q4
$172M Buy
3,059,460
+9,853
+0.3% +$577K 0.91% 21
2016
Q3
$182M Sell
3,049,607
-21,587
-0.7% -$1.26M 0.99% 16
2016
Q2
$169M Buy
3,071,194
+136,595
+5% +$7.27M 0.94% 19
2016
Q1
$148M Buy
2,934,599
+57,862
+2% +$2.83M 0.85% 22
2015
Q4
$145M Buy
2,876,737
+82,020
+3% +$4.14M 0.85% 23
2015
Q3
$132M Buy
2,794,717
+108,532
+4% +$5.77M 0.82% 25
2015
Q2
$146M Buy
2,686,185
+53,133
+2% +$2.98M 0.87% 17
2015
Q1
$144M Buy
2,633,052
+108,187
+4% +$6.13M 0.87% 15
2014
Q4
$137M Sell
2,524,865
-25,855
-1% -$1.44M 0.86% 19
2014
Q3
$144M Buy
2,550,720
+176,190
+7% +$9.89M 0.93% 18
2014
Q2
$131M Sell
2,374,530
-13,344
-0.6% -$728K 0.91% 19
2014
Q1
$129M Buy
2,387,874
+30,961
+1% +$1.6M 0.93% 17
2013
Q4
$113M Buy
2,356,913
+26,121
+1% +$1.19M 0.82% 19
2013
Q3
$106M Sell
2,330,792
-24,342
-1% -$1.11M 0.86% 19
2013
Q2
$104M Buy
+2,355,134
New +$105M 0.91% 19

Other funds holding MRK

Chevy Chase Trust's MRK Position: Q1 2026 in Review

Chevy Chase Trust reduced its Merck (MRK) stake by 3% in Q1 2026, selling an estimated $4.43M and leaving 1,253,128 shares worth $151M. The position accounts for 0.43% of the portfolio, ranked #45.

Chevy Chase Trust first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $206M in Q4 2019. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Chevy Chase Trust held 1,253,128 shares of Merck worth $151M as of Q1 2026.
  • Chevy Chase Trust sold 38,375 Merck shares in Q1 2026, an estimated $4.43M.
  • Merck made up 0.43% of Chevy Chase Trust's portfolio in Q1 2026, its #45 holding.
  • Chevy Chase Trust first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Chevy Chase Trust's Merck position peaked at $206M in Q4 2019.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Chevy Chase Trust's 13F filing for Q1 2026, filed 15 May 2026.